Immunome (NASDAQ:IMNM) reported its Q4 earnings results on Monday, March 28, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Immunome beat estimated earnings by 19.75%, reporting an EPS of $-0.65 versus an estimate of $-0.81.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16 which was followed by a 0.9% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
